Gold Crest Retirement Center | |
200 Levi Lane, Adams, Nebraska 68301 | |
(402) 988-7115 | |
Name | Gold Crest Retirement Center |
---|---|
Location | 200 Levi Lane, Adams, Nebraska |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 52 |
Occupancy Rate | 86.35% |
Medicare ID (CCN) | 285065 |
Legal Business Name | Coffman-levi Charitable Trust, Inc |
Ownership Type | Non Profit - Corporation |
NPI Number | 1164415816 |
Organization Name | COFFMAN-LEVI CHARITABLE TRUST, INC |
Doing Business As | GOLD CREST RETIREMENT CENTER |
Address | 200 Levi Ln, Adams, NE 68301 |
Phone Number | 402-988-7115 |
News Archive
The Fastep® COVID-19 IgG/IgM Rapid Test Device by Assure Tech., distributed in the USA by Carolina Liquid Chemistries, has received FDA Emergency Use Authorization for use.
Lifeline Vascular Access(SM), the nation's leading provider of vascular access management services, today announced that Dr. Stephen Osaguona has been awarded the 2009 Gerald A. Beathard Fellowship in Interventional Nephrology.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 study of PV-10 for metastatic melanoma will be presented at the HemOnc Today - Melanoma and Cutaneous Malignancies Conference on April 13, 2012.
The origins of many adult diseases can be traced to early negative experiences associated with social class and other markers of disadvantage.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The Fastep® COVID-19 IgG/IgM Rapid Test Device by Assure Tech., distributed in the USA by Carolina Liquid Chemistries, has received FDA Emergency Use Authorization for use.
Lifeline Vascular Access(SM), the nation's leading provider of vascular access management services, today announced that Dr. Stephen Osaguona has been awarded the 2009 Gerald A. Beathard Fellowship in Interventional Nephrology.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 study of PV-10 for metastatic melanoma will be presented at the HemOnc Today - Melanoma and Cutaneous Malignancies Conference on April 13, 2012.
The origins of many adult diseases can be traced to early negative experiences associated with social class and other markers of disadvantage.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.42 | 14.46 |
Percentage of long-stay residents who lose too much weight | 2.86 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 77.33 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.54 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.37 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 22.45 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.67 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 17.81 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.3 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 13.53 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 1.39 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 4.21 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 95.03 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.68 | 82.93 |
News Archive
The Fastep® COVID-19 IgG/IgM Rapid Test Device by Assure Tech., distributed in the USA by Carolina Liquid Chemistries, has received FDA Emergency Use Authorization for use.
Lifeline Vascular Access(SM), the nation's leading provider of vascular access management services, today announced that Dr. Stephen Osaguona has been awarded the 2009 Gerald A. Beathard Fellowship in Interventional Nephrology.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 study of PV-10 for metastatic melanoma will be presented at the HemOnc Today - Melanoma and Cutaneous Malignancies Conference on April 13, 2012.
The origins of many adult diseases can be traced to early negative experiences associated with social class and other markers of disadvantage.
› Verified 7 days ago